= sanofi Q Home > YourHealth > Medicines > Cardiovascular Diseases Cardiovascular diseases Cardiovascular deaths can be prevented, and we won't stop our efforts until every possible life is saved. “To reduce the global impact of cardiovascular disease demands bold new thinking. We are going beyond medicines as a leader in efforts that aim to positively impact the lives Olivier Charmeil of millions of patients who Executive Vice President and " . . ” Global Head of General live with these diseases’ Medicines Did you know? No. 1 Over 30%Cardiovascular diseases (CVDs) are the Nearly a third of the total number of global leading cause of death globally. deaths are due to CVDs. Over 75% Over three quarters of CVD deaths take place in low and middle income countries. The burden of cardiovascular disease Cardiovascular diseases are disorders of the heart and blood vessels which can result in heart attacks, strokes and other CV events, which are mainly caused bya blockage in blood vessels that prevents blood from flowing to the heart or brain, The cause of cardiovascular diseases is usually a combination of risk factors, such as tobacco use, diet, obesity, physical inactivity, harmful use of alcohol, hypertension, diabetes or high cholesterol’.Optimizing lipid management in acute coronary syndrome ‘Acute coronary syndrome (ACS) is a major cause of death & illness worldwide and post-ACS patients are at very high risk of recurrent cardiovascular events. Since 2018, Sanofi has developed and supported the ACS EuroPath project, to identify and address the barriers to optimal lipid management in post-ACS patients. View the infographic ns Read the article >Antiplatelet agents Anticoagulants Blood pressure lowering agents A leader in the fight against CVD Sanofi has dedicated 60 years to understanding cardiovascular diseases, continuously evolving and working closely with healthcare partners to provide solutions. We are proud to bea healthcare organization that offers a complete range of medications for high-risk cardiovascular patients and their physicians References 1. World Health Organization (2022) Cardiovascular diseases (CVDs). Accessed October 2022 MAT-GLB-2300092 v1.0 01/2023Contact. Legal notice Privacy & data protection Cookies Policy Code of Conduct Our publications Sitemap Directory Accessibility: partial compliance Sanofi Today © Sanofi 2004-2023 - All rights reserved